文献速递老年与多病共存慢病管理常见症状与未分化疾病

在多重用药老年患者中明确治疗优先事项对抗分析药处方的影响

Impact of eliciting treatment priorities on analgesic prescribing in older patients with high levels of polypharmacy.
PubMed 文献 · Fam Pract · 2025-01-01

该研究为SPPiRE试验的二次队列分析,纳入403例平均年龄76.5岁的多重用药老年患者,评估患者自报与全科医生记录的治疗优先事项一致性及疼痛优先对镇痛药处方的影响。结果显示患者与医生对疼痛优先的记录一致性差(kappa 0.118,P=0.05),且疼痛优先与阿片类药物强化处方风险增加相关,尽管指南不建议将阿片类药物用于慢性疼痛。

要点

  • 患者自报与全科医生记录的疼痛优先事项一致性差,kappa仅0.118。
  • 研究期间多数镇痛药处方减少,但强阿片类药物处方在两组中均增加。
  • 疼痛优先(自报、医生记录或基线EQ5D严重疼痛)均与随访时阿片类药物强化处方风险增加相关。

核心结论

  • 在多重用药老年患者中,将疼痛确定为优先事项与阿片类药物处方强化可能性增加相关,尽管指南建议不要将阿片类药物用于慢性疼痛。

研究设计与样本

  • SPPiRE试验的二次队列分析及过程评估,纳入403例平均年龄76.5岁的多重用药老年患者。
  • 评估基线患者自报优先事项与干预组全科医生在药物审查中记录的优先事项,一致性用Cohen kappa评估。
  • 使用多水平模型分析疼痛(自报、医生记录、基线EQ5D严重或极度疼痛)对阿片类药物强化处方的影响,并考虑全科诊所聚类和干预效应。

主要发现

  • 178例(44.2%)患者在基线自报疼痛为优先事项。
  • 患者自报与全科医生记录的疼痛一致性差(kappa 0.118,P=0.05)。
  • 研究期间多数镇痛药处方减少,但强阿片类药物在两组中均增加。
  • 所有三种疼痛变量均与随访时阿片类药物强化处方风险增加相关;当全科医生在药物审查中记录疼痛为优先事项时,患者阿片类药物处方强化的可能性是未记录者的2.73倍。

临床怎么用

  • 全科医生应意识到患者疼痛优先与阿片类药物强化处方相关,需谨慎权衡指南建议与患者优先事项。
  • 在多重用药老年患者的药物审查中,应关注疼痛管理,避免不适当的阿片类药物强化。

局限性

  • 本研究为二次队列分析,可能受混杂因素影响。
  • 患者与全科医生对优先事项记录的一致性差,可能影响结果解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Multimorbidity guidelines recommend tailoring care to patients' priorities. The Supporting Prescribing in Multimorbidity in Primary Care (SPPiRE) trial focused on optimizing medicines use in older adults with significant polypharmacy and tailoring prescribing and deprescribing to individual priorities. This study aimed to compare self-reported and general practitioner (GP)-recorded patient priorities and examine the impact of prioritizing pain on analgesic prescribing. METHODS: This secondary cohort analysis of the SPPIRE trial and process evaluation assessed baseline participant-identified priorities and intervention group GP-recorded priorities during medication reviews with agreement assessed using Cohen's kappa. Analgesic prescribing patterns and daily morphine milligram equivalents changes during the study period were summarized. The impact of pain (self-reported, GP-recorded, and severe or extreme pain on the baseline EQ5D) on opioid intensification was analysed using multi-level models accounting for GP practice clustering and intervention effects. RESULTS: A total of 403 patients (mean age 76.5 years) were included; 178 (44.2%) reported pain as a priority at baseline. Agreement between self-reported and GP-recorded pain was poor (kappa 0.118, P = 0.05). Most analgesic prescriptions decreased during the study, except for potent opioids, which increased in both trial arms. All three pain variables were associated with increased odds of opioid intensification at follow-up. CONCLUSION: In this older population of patients with significant polypharmacy, identifying pain as a priority was associated with an increased likelihood of opioid intensification, despite guidelines advising against their use for chronic pain. This study highlights the challenges faced by GPs treating pain in older adults with multimorbidity. Guidelines for managing patients with multiple health conditions recommend focusing on what matters most to patients. The Supporting Prescribing in Multimorbidity in Primary Care (SPPiRE) trial aimed to improve medication use in older adults prescribed ≥ 15 medicines by aligning prescribing decisions with individual patient priorities. This study analysed data from the SPPiRE trial to assess how often patients and general practitioners (GPs) agreed on treatment priorities and how prioritizing pain affected painkiller prescribing. This study included data on 403 older adults (average age 76.5 years), 178 of whom self-reported pain as a priority for treatment when returning postal questionnaires at the start of study. Overall, agreement between patients and GPs on treatment priorities was poor. When assessing changes in painkiller prescribing in all patients (those who had a medication review and those who did not) prescriptions for most painkillers reduced during the study period, but prescriptions for stronger opioids increased. When GPs recorded pain as a treatment priority during the medication review, patients were 2.73 times more likely to have their opioid prescribing intensified compared to patients whose pain was not recorded as a priority in their medication review. This is despite clinical practice guidelines advising not to use opioids to treat chronic pain.

来源:Fam Pract,查看原文。版权归原作者所有。

引用

  1. McCarthy C, Clyne B, Smith SM, et al. Impact of eliciting treatment priorities on analgesic prescribing in older patients with high levels of polypharmacy. Fam Pract. 2025. PMID: 40720208. doi:10.1093/fampra/cmaf056

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。